| 摘要 |
<p>The present invention relates to polymorphic forms of a compound of formula A: This compound is useful as a glucagon receptor antagonist and serves as a pharmaceutically active ingredient for the treatment of type 2 diabetes and related conditions, such as hyperglycemia, obesity, dyslipidemia, and the metabolic syndrome. Hydrates, hemihydrates, anhydrates and similar polymorphic forms are included.</p> |
| 申请人 |
MERCK SHARP & DOHME CORP.;CHUNG, JOHN, Y., L.;ZHANG, YANFENG;ARTINO, LAURA;BAXTER, JENNIFER;COTE, AARON, S.;DESMOND, DONAL;SCOTT, JEREMY;VAYNSHTEYN, YEKATERINA |
发明人 |
CHUNG, JOHN, Y., L.;ZHANG, YANFENG;ARTINO, LAURA;BAXTER, JENNIFER;COTE, AARON, S.;DESMOND, DONAL;SCOTT, JEREMY;VAYNSHTEYN, YEKATERINA |
